Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic–ischemic brain injury in neonatal rats

[1]  A. Malhotra,et al.  Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury: A Systematic Review & Meta-Analysis of Preclinical Studies , 2022, bioRxiv.

[2]  M. Ando,et al.  Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial , 2022, BMJ Open.

[3]  G. Schmitt,et al.  The benefits, limitations and opportunities of preclinical models for neonatal drug development , 2022, Disease models & mechanisms.

[4]  K. Abe,et al.  Non-Tumorigenic Pluripotent Reparative Muse Cells Provide a New Therapeutic Approach for Neurologic Diseases , 2021, Cells.

[5]  M. Akiyama,et al.  Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  H. Iida,et al.  Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  K. Abe,et al.  Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis , 2020, Scientific Reports.

[8]  K. Nishigaki,et al.  Safety and Efficacy of Human Muse Cell-Based Product for Acute Myocardial Infarction in a First-in-Human Trial. , 2020, Circulation journal : official journal of the Japanese Circulation Society.

[9]  T. Tominaga,et al.  Intravenously Transplanted Human Multilineage-Differentiating Stress-Enduring Cells Afford Brain Repair in a Mouse Lacunar Stroke Model , 2019, Stroke.

[10]  H. Lv,et al.  Neonatal hypoxic–ischemic encephalopathy: emerging therapeutic strategies based on pathophysiologic phases of the injury , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[11]  M. Iino,et al.  Rescue from Stx2-Producing E. coli-Associated Encephalopathy by Intravenous Injection of Muse Cells in NOD-SCID Mice , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  P. Sanberg,et al.  May the force be with you: Transfer of healthy mitochondria from stem cells to stroke cells , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  M. Tsuji,et al.  Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat , 2018, Front. Neurol..

[14]  Thomas K. Watanabe.  A Review of Stem Cell Therapy for Acquired Brain Injuries and Neurodegenerative Central Nervous System Diseases , 2018, PM & R : the journal of injury, function, and rehabilitation.

[15]  Y. Chang,et al.  Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy , 2018, Scientific reports.

[16]  M. Dezawa,et al.  Human Multilineage-differentiating Stress-Enduring Cells Exert Pleiotropic Effects to Ameliorate Acute Lung Ischemia–Reperfusion Injury in a Rat Model , 2018, Cell transplantation.

[17]  C. Muramatsu,et al.  S1P–S1PR2 Axis Mediates Homing of Muse Cells Into Damaged Heart for Long-Lasting Tissue Repair and Functional Recovery After Acute Myocardial Infarction , 2018, Circulation research.

[18]  Y. Kondo,et al.  Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[19]  G. van Echten-Deckert,et al.  Sphingosine 1-phosphate - A double edged sword in the brain. , 2017, Biochimica et biophysica acta. Biomembranes.

[20]  F. Motoi,et al.  Human Muse Cells, Nontumorigenic Phiripotent-Like Stem Cells, Have Liver Regeneration Capacity through Specific Homing and Cell Replacement in a Mouse Model of Liver Fibrosis , 2017, Cell transplantation.

[21]  B. Tatlı,et al.  Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment , 2017, Expert review of neurotherapeutics.

[22]  K. Nakanishi,et al.  Rat umbilical cord blood cells attenuate hypoxic–ischemic brain injury in neonatal rats , 2017, Scientific Reports.

[23]  K. Nakanishi,et al.  Dedifferentiated Fat Cells as a Novel Source for Cell Therapy to Target Neonatal Hypoxic-Ischemic Encephalopathy , 2017, Developmental Neuroscience.

[24]  T. Tominaga,et al.  Human Muse Cells Reconstruct Neuronal Circuitry in Subacute Lacunar Stroke Model , 2017, Stroke.

[25]  M. Dezawa.  Muse Cells Provide the Pluripotency of Mesenchymal Stem Cells: Direct Contribution of Muse Cells to Tissue Regeneration , 2016, Cell transplantation.

[26]  C. Svendsen,et al.  Regenerative cellular therapies for neurologic diseases , 2016, Brain Research.

[27]  Steven P. Miller,et al.  Rodent Hypoxia–Ischemia Models for Cerebral Palsy Research: A Systematic Review , 2016, Front. Neurol..

[28]  K. Ohno,et al.  Neuroprotective potential of molecular hydrogen against perinatal brain injury via suppression of activated microglia. , 2016, Free radical biology & medicine.

[29]  H. Mushiake,et al.  Transplantation of Unique Subpopulation of Fibroblasts, Muse Cells, Ameliorates Experimental Stroke Possibly via Robust Neuronal Differentiation , 2016, Stem cells.

[30]  John H. Zhang,et al.  Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy , 2015, International journal of molecular sciences.

[31]  P. Walczak,et al.  The Dark Side of the Force – Constraints and Complications of Cell Therapies for Stroke , 2015, Front. Neurol..

[32]  H. Moore,et al.  Therapeutic Hypothermia and Hypoxia-Ischemia in the Term-equivalent Neonatal Rat: Characterization of a Translational Pre-clinical Model , 2015, Pediatric Research.

[33]  Hye Soo Yoo,et al.  Hypothermia Augments Neuroprotective Activity of Mesenchymal Stem Cells for Neonatal Hypoxic-Ischemic Encephalopathy , 2015, PloS one.

[34]  K. Blomgren,et al.  Administration of Umbilical Cord Blood Cells Transiently Decreased Hypoxic-Ischemic Brain Injury in Neonatal Rats , 2015, Developmental Neuroscience.

[35]  A. Kurisaki,et al.  Therapeutic Potential of Adipose‐Derived SSEA‐3‐Positive Muse Cells for Treating Diabetic Skin Ulcers , 2015, Stem cells translational medicine.

[36]  Tomohiko Nakamura,et al.  Incidence and prediction of outcome in hypoxic–ischemic encephalopathy in Japan , 2014, Pediatrics international : official journal of the Japan Pediatric Society.

[37]  K. Blomgren,et al.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.

[38]  S. Auvin,et al.  Comparison of Brain Maturation among Species: An Example in Translational Research Suggesting the Possible Use of Bumetanide in Newborn , 2013, Front. Neurol..

[39]  K. Blomgren,et al.  Grafting of neural stem and progenitor cells to the hippocampus of young, irradiated mice causes gliosis and disrupts the granule cell layer , 2013, Cell Death and Disease.

[40]  M. Dezawa,et al.  Regenerative Effects of Mesenchymal Stem Cells: Contribution of Muse Cells, a Novel Pluripotent Stem Cell Type that Resides in Mesenchymal Cells , 2012, Cells.

[41]  Shabari Tipnis,et al.  Radiolabeling of umbilical cord-derived mesenchymal stem cells for in vivo tracking. , 2012, Cancer biotherapy & radiopharmaceuticals.

[42]  J. Volpe,et al.  Neonatal encephalopathy: An inadequate term for hypoxic–ischemic encephalopathy , 2012, Annals of neurology.

[43]  William A Catterall,et al.  Autistic behavior in Scn1a+/− mice and rescue by enhanced GABAergic transmission , 2012, Nature.

[44]  K. Polderman,et al.  Is therapeutic hypothermia immunosuppressive? , 2012, Critical Care.

[45]  S. Czasch,et al.  Proliferative and Nonproliferative Lesions of the Rat and Mouse Central and Peripheral Nervous Systems , 2012, Toxicologic pathology.

[46]  Y. Fujiyoshi,et al.  Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts , 2011, Proceedings of the National Academy of Sciences.

[47]  Nadia Badawi,et al.  Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. , 2010, Early human development.

[48]  A. Inutsuka,et al.  Unique multipotent cells in adult human mesenchymal cell populations , 2010, Proceedings of the National Academy of Sciences.

[49]  Andrew Whitelaw,et al.  Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data , 2010, BMJ : British Medical Journal.

[50]  A. Oohira,et al.  Chondroitin sulfate, a major niche substance of neural stem cells, and cell transplantation therapy of neurodegeneration combined with niche modification. , 2009, Current stem cell research & therapy.

[51]  K. Nakanishi,et al.  Reduction of Brain Injury in Neonatal Hypoxic—Ischemic Rats by Intracerebroventricular Injection of Neural Stem/Progenitor Cells Together With Chondroitinase ABC , 2008, Reproductive Sciences.

[52]  William Oh,et al.  Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. , 2005, The New England journal of medicine.

[53]  C. Ober,et al.  HLA‐G and immune tolerance in pregnancy , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  Xuezhi Sun,et al.  Ectopic neurons in the hippocampus may be a cause of learning disability after prenatal exposure to X-rays in rats. , 2004, Journal of radiation research.

[55]  M. Johnston,et al.  Apoptosis Has a Prolonged Role in the Neurodegeneration after Hypoxic Ischemia in the Newborn Rat , 2000, The Journal of Neuroscience.

[56]  T. Schallert,et al.  CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury , 2000, Neuropharmacology.

[57]  R. Morris.  Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[58]  S. Papson,et al.  “Model” , 1981 .

[59]  J. Rice,et al.  The influence of immaturity on hypoxic‐ischemic brain damage in the rat , 1981, Annals of neurology.

[60]  F. Ebaugh,et al.  The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination or red cell survival in vivo. , 1953, The Journal of clinical investigation.

[61]  S. Gray,et al.  Determination of the circulating red cell volume in man by radioactive chromium. , 1950, The Journal of clinical investigation.

[62]  M. Dezawa,et al.  Muse Cells Are Endogenous Reparative Stem Cells. , 2018, Advances in experimental medicine and biology.

[63]  Stephen Ashwal,et al.  Comparison of Two Neonatal Ischemic Injury Models Using Magnetic Resonance Imaging , 2007, Pediatric Research.

[64]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .